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Aneurysm Sac Pressure after EVAR: The Role of Endoleak
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Objective. The relation between endoleak and aneurysm sac pressure is not completely clear. This review evaluates the effect of
endoleaks on aneurysm sac pressure and summarizes the present knowledge regarding aneurysm sac pressure after EVAR.
Methods. A systematic search of literature was carried out using MEDLINE, EMBASE and Web of Science. Studies were
included if aneurysm sac pressure measurements as well as systemic pressure measurements were performed during or after
EVAR. Mean pressure indices (MPI), ratio mean aneurysm sac pressure to mean systemic pressure), in the absence of
endoleaks and in the presence of different type of endoleaks were compared.
Results. Stent-graft deployment does not seem to result in immediate reduction of aneurysm sac in the absence of an
endoleak. Aneurysm sac pressure is elevated in the presence of an endoleak. However, the MPIs differ widely between
studies both in the absence and presence of an endoleak.
Conclusion. MPI is not specific to the type of endoleak. This implies that the same type of endoleak does not necessarily
pose the same MPI and by this the same hazard of aneurysm rupture, because the aneurysm sac pressure is directly related
to the aneurysm wall stress.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Endovascular aneurysm repair (EVAR) was intro-
duced in 1991 as a less-invasive alternative for
abdominal aortic aneurysm (AAA) therapy.1,2 EVAR
aims at prevention of aneurysm rupture with exsan-
guinations and acute death. Endoleaks are the
Achilles heel of EVAR. An endoleak is defined as per-
sistence of blood flow outside the stent-graft, but
within the aneurysm sac. Endoleaks occur approxi-
mately in 20% of the patients treated by EVAR.3
The absence of an endoleak on conventional imag-
ing tools, such as Computer tomography (CT) or angi-
ography, does not exclude the possibility of high
pressure in the aneurysm sac and the persistent risk
of rupture.4 Therefore the concept of endotension is
formulated as persistent or recurrent pressurization
of the aneurysm sac following endovascular repair.5
The success of EVAR relies on the extent of isola-
tion of the aneurysm sac from systemic blood flow
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of isolation is difficult. Firstly, it is not known what
happens to the aneurysm sac pressure after EVAR
without detectable endoleak nor is it known how
much pressure is required to cause rupture. Secondly,
it is difficult to predict whether and when re-interven-
tion is justified in the presence of endoleaks, solely
based on imaging. Graft related endoleaks (Type I
and III) are associated with a risk of late rupture
and it is assumed but not proven that this is because
such endoleaks are associated with significant pres-
surization of the aneurysm sac.4 The treatment of
endoleaks from collateral back-flow (Type II) remains
controversial. Many state that Type II endoleaks will
seal.4,6 It has been proposed that most Type II endo-
leaks that seal are those detected at the original proce-
dure.4 Little is known about their impact on the
aneurysm sac pressure and the risk of aneurysm
rupture. The clinical significance of Type V endoleaks,
defined as aneurysm growth without detectable endo-
leaks, also remains uncertain.
Elucidation of the relationship between endoleak
and pressure may help clinical decision making. This
review evaluates the effect of endoleaks on aneurysmlar Surgery. Published by Elsevier Ltd. All rights reserved.
433Aneurysm Sac Pressure after EVARsac pressure and summarizes the present knowledge
regarding aneurysm sac pressure after EVAR.
Methods
Search strategy for identification of studies
A systemic search of literature was conducted until
December 2006 using PubMed, EMBASE and Web of
Science. Our search strategy is given in Table 1
(PubMed), Table 2 (EMBASE) and Table 3 (Web of
Science). There was no restriction on language.
Criteria for considering studies for this review
Articles of in-vitro, animal and patient-studies were
selected by Pubmed, EMBASE and Web of Science, re-
spectively. The abstracts of each article were studied
after checking for duplication between the databases.
If it appeared that aneurysm sac pressure measure-
ments was concurrently performed with systemic
pressure measurements during or after EVAR the
full text was studied. Additional articles were sought
by checking the reference lists of the relevant articles.
Data extraction
Particular attention during evaluation of the selected
studies was paid to the type of study (in-vitro, animal
or patient), the pressure measurement technique, the
presence or absences of endoleaks, the time of pres-
sure measurement and the used analysis of pressure
measurements. The endoleak classification is given
in Table 4.6
The interval between pressure measurement and
EVAR might be relevant for the interpretation and
Table 1. Search strategy used for PubMed
Search
#1 ‘‘aortic aneurysm’’ [MeSH] OR aortic aneurysm* [Text word]
#2 ‘‘stents’’ [MeSH] OR stent* [Text Word]
#3 ‘‘blood vessel prosthesis’’ [MeSH] OR ‘‘blood vessel
prosthesis implantation’’ MeSH] OR blood vessel prosthe*
[Text Word]
#4 evar [All Fields] OR ‘‘endovascular therapy’’ [All Fields]
#5 #2 OR #3 OR #4
#6 #1 AND #5
#7 endovascular [All Fields] AND (‘‘aneurysm’’ [MeSH Terms]
OR aneursym* [Text Word]) AND (repair* [Text Word] OR
treat* [Text Word] OR therap* [Text Word] OR explode
therapy [Subheading] OR ‘‘therapeutics’’ [MeSH])
#8 ‘‘pressure’’ [MeSH] OR pressure* [Text Word] OR
‘‘manometry’’ [MeSH] OR manomet* [All fields] OR leak*
[All Fields] OR endoleak* [All Fields] OR tension [All fields]
OR endotension [All Fields]
#9 #8 AND (#6 OR #7)comparison of measurements. Therefore, we catego-
rized the studies, in which an endoleak was absent,
in 4 groups (Group 1: < 1 week after EVAR, Group
2: 1 week to 1 year after EVAR, Group 3: 1 to 2 years
after EVAR, Group 4: 2 to 4 years after EVAR). We di-
vided the studies, in which a Type II endoleak was
present, in 2 groups (Group 1: 0 to 1 month after
EVAR, Group 2: > 1 month after EVAR). Time of pres-
sure measurement is probably less relevant in the
presence of a Type I and III leak, because there is a di-
rect connection between the systemic circulation and
the aneurysm sac. Consequently, it is not likely that
the ratio between aneurysm sac pressure and systemic
blood pressure changes over time. Type IV and V
endoleak studies were not categorized in moment of
pressure measurement, because these endoleaks are
investigated only in a small number of studies.
Analysis of data
Peripherally measured systolic and diastolic pressure
does not always reflect corresponding pressures in
the aorta. The systolic pressure in the brachial artery
over-estimates the central aortic systolic pressure.7 So
the comparison of the ratios between the systolic or
Table 2. Search strategy used for EMBASE (OVID)
Search
1 exp aorta aneurysm/OR aortic aneurys$.ft
2 stent/OR stent$.ft
3 exp blood vessel prosthesis/OR blood vessel prosthe$.ft
4 endovascular therap$.ft
5 evar.ft OR endovascular aneurysm repair.ft
6 endovascular aneurysm treat$.ft OR endovascular
aneurysm therap$.ft
7 (1 AND (2 OR 3 OR 4)) OR (5 OR 6)
8 pressure/OR pressure measurement/OR pressure$.ft
9 manometry/OR manomet$.ft
10 tension/OR tension.ft
11 leakage.ft OR endotens$.ft OR endoleak$.ft
12 exp prosthesis failure/OR prosthesis fail$.ft
13 8 OR 9 OR 10 OR 11 OR 12
14 7 AND 13
Table 3. Search strategy used for Web of Science
Search
#1 TS¼ (pressure* or manomet* or leak* or endoleak* or
tension or endotension)
#2 TS¼ aortic aneurysm*
#3 TS¼ (stent* or blood vessel prosthe* or evar or
endovascular therap*)
#4 TS¼ endovascular
#5 TS¼ (repair* or treat* or therap*)
#6 #3 AND #2
#7 TS¼ aneurysm*
#8 #7 AND #5 AND #4
#9 #8 OR #6
#10 #9 AND #1
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pressure between studies, in which the systemic blood
pressure is measured centrally, and studies, in which
this pressure is measured peripherally, is biased. How-
ever, the mean pressure is virtually identical in central
and peripheral arteries.8 Therefore, we chose to evalu-
ate the mean pressure index (MPI) to enable meaning-
ful comparisons. The MPI is the ratio between the
mean aneurysm sac pressures and the mean systemic
blood pressure (MPI). If no single aneurysm sac and
systemic pressure were given, we depicted the ratio
between the reported mean or median aneurysm sac
pressure and the mean or median systemic blood pres-
sure of the experiments.
Data were stored in a database for analyses (Micro-
soft Excel 2002, Redmond, USA). The mean pressure




III Failure of graft
IV Porosity of graft wall
V Endotensionindices (MPIs) were compared between studies. MPIs
were depicted in Box & Whisker plots.
The effect of stent-graft deployment and the occur-
rence of endoleaks on the pulse pressure in the aneu-
rysm sac were evaluated as well. Because of the
difference between centrally and peripherally mea-
sured blood pressures, no quantitative analysis of
the pulse pressure was performed.
Results
Aneurysm sac pressure without endoleak
Dampening of pulse pressure after stent-graft deploy-
ment without endoleak was observed in all studies.
Pulse pressure in the aneurysm sac was never totally
eliminated.9e35
Patient-studies
In literature, the mean pressure index (MPI) in pa-
tients after EVAR without detectable endoleak ranges
from 0 to 1.2 (Fig. 1AeD, red lines).9e36 Patient-
studies demonstrate that stent-graft deploymentFig. 1. MPI without endoleak in patient-studies (red), animal-studies (green) and in-vitro studies (blue). Type of pressure
measurement device is given by (??) unknown, (F) fluid filled or (NF) non-fluid filled.
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sac pressure. However, Chuter et al. and Gawenda
et al. recorded a lower MPI immediately after aneu-
rysm exclusion than other patient-studies (Fig. 1A,
red lines).22,30 They deployed aorto-mono-iliac stent-
grafts instead of bifurcated. Other patient-studies con-
firm (Fig. 1AeD, red lines) the suggestion that time is
required before pressure reduction in the aneurysm
sac takes place. Ellozy et al. performed experiments
with wireless pressure sensors to monitor aneurysm
sac pressure continuously. They demonstrated that af-
ter EVAR the ratio of aneurysm sac pressure to sys-
temic pressure decreased, except in 2 patients, from
the time of implantation to 1 month and 3 months, re-
spectively (Fig. 1B, red lines).13
Animal-studies
In animal studies, it has alsobeen reported that the intra-
aneurysm sac pressure after EVAR without endoleak is
not immediately eliminated. Pitton et al. reported a pres-
sure reduction during the period from 6 weeks to
6 months after EVAR (Fig. 1B, green lines).15,16
In-vitro studies
In in-vitro studies, recorded MPIs are consistently
lower than those reported in in-vivo studies. All in-
vitro studies, except the study by Chaudhuri et al.,12
reported a MPI less than 0.55 after successful exclu-
sion of the aneurysm sac (Fig. 1A, blue lines).
Aneurysm sac pressure with type I endoleak
All studies, in which the effect of type I endoleak on
the pulse pressure was investigated, demonstrated
that aneurysm sac pulse pressure is less reduced in
the presence of type I endoleaks than in the absence
of type I endoleaks.12,18,21,30,37
Patient-studies
The MPI in patients with type I endoleak ranges from
0.76 to 1.08.21,30,37 (Fig. 2, red lines).
Animal-studies
Criado et al. investigated only the aneurysm sac pres-
sure in animals in the presence of a type I endoleak.
The pressure differential between the aneurysm
sac pressure and systemic pressure was in 3 dogs
<5 mmHg (MPI 1) (Fig. 2, green line).38
In-vitro studies
The MPI in in-vitro studies, in which type I endoleaks
are investigated, varies from 0.26 to 1.07.12,17,18 TheMPIs reported by Xenos et al. are lower than those re-
ported by other studies (Fig. 2, blue lines).17
Aneurysm sac pressure with type II endoleak
In spite of the presence of a type II endoleak,
the pulse pressure in the aneurysm sac is reduced
when compared to the systemic pulse
pressure.9,10,12e16,21,33,37,39,40
Patient-studies
MPIs in the first month after EVAR, in patients
with type II endoleaks, vary between 0.5 and 1.0.
However, aneurysm sac pressure during this period
appears similar to systemic pressure in most
patients with type II endoleak (Fig. 3A, red
lines).12,13,15e17,21,33,36,37,39,41e43
MPIs, measured at more than 1 month after EVAR,
in patients with type II endoleaks, range from 0.2 to
1.0.9,10,13e16,33,44 Ellozy et al. measured aneurysm sac
pressure immediately after EVAR in a patient with
a type II endoleak, at 1 month and at 3 months after
EVAR. The MPI decreased from 1.0 to 0.95 and 0.72,
respectively.13 MPIs, measured by Dias et al. more
than 1 month after EVAR (Fig. 3B), are generally lower
than those measured in the first month after EVAR
(Fig. 3A). These findings imply that aneurysm sac
pressure also decreases after a time interval in spite
of the presence of a persisting type II endoleak.
However, aneurysm sac pressure does not always
decrease in the presence of type II endoleak
(Fig. 3B).44
Animal-studies
The MPIs in animals in the first month after EVAR
ranges from 0.33 to 0.85 (Fig. 3A, green lines) and at
more than 1 month after EVAR from 0.42 to 0.94
(Fig. 3B, green lines).9,10,15,16,33,40e42 Pitton et al.
Fig. 2. MPI with type I endoleak in patient-studies (red),
animal-studies green) and in-vitro studies (blue). Type of
pressure measurement device is given by (??) unknown,
(F) fluid filled or (NF) non-fluid filled device.
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time. The MPI after 6 months was lower than after
6 weeks (Fig. 3B).15,16
In-vitro studies
The MPIs in in-vitro studies, in which type II endo-
leaks are investigated, ranges froms 0.10 to 0.88
(Fig. 3A, blue lines).12,17 Xenos et al. did not demon-
strate in their in-vitro model a significant increase in
the aneurysm sac pressure in the presence of flow
through a type II endoleak (Fig. 3A).17
Aneurysm sac pressure with type III endoleak
The pulse pressures in the aneurysm sacs with type III
endoleaks were reduced, but to a lesser extent than
without endoleak.19,23,25,26,31 Aneurysm sac pulse
pressure was also depended on the presence or ab-
sence of outflow from the aneurysm sac.19,23
Fig. 3. MPI with type II endoleak in patient-studies (red),
animal-studies (green) and in-vitro studies (blue). Type of
pressure measurement device is given by (??) unknown,
(F) fluid filled or (NF) non-fluid filled device.
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The MPIs in animal-studies, in case of type III endo-
leak, range from 0.27 to 1.00 (Fig. 4, green lines).26,45
In-vitro studies
In-vitro studies with type III endoleaks demonstrated
a MPI from 0 to 1.96 (Fig. 4, blue lines).19,23,25,31 Wint-
zer et al. investigated aneurysm sac pressure in an
in-vitro model. They demonstrated that the MPI de-
pended on the presence of outflow from the aneurysm
sac and on the pressure inside this outflow channel.
In the absence of outflow through collateral vessels
the mean pressure in the aneurysm will increase to
mean pressure of the systemic circulation. However,
type III endoleak with free outflow without resistance
through the open inferior mesenteric artery (IMA) re-
sulted in an aneurysm sac pressure of 0 mmHg. In the
presence of the IMA, with a pressure of 100 mmHg,
the aneurysm sac pressure appeared to be
96 mmHg.31 All these conditions are illustrated in
Fig. 4.
Furthermore, Mehta et al. demonstrated that the an-
eurysm sac pressure is equivalent to that of the sys-
temic circulation if a type III endoleak and lumbar
outflow are present. In the presence of type III endo-
leak without lumbar branch outflow, the aneurysm
sac pressure was higher than that of the systemic
circulation.19 This corresponds with the findings by
Parodi et al. (Fig. 4).23
Aneurysm sac pressure with type IV endoleak
Three studies, one animal (Fig. 5, green line) and two
in-vitro studies (Fig. 5, blue lines), are performed to
investigate the effect of stent-graft porosity on the
Fig. 4. MPI with type III endoleak in patient-studies (red),
animal-studies (green) and in-vitro studies (blue). Type of
pressure measurement device is given by (??) unknown,
(F) fluid filled or (NF) non-fluid filled device.
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was present, the pulse pressure in the aneurysm sac
was reduced in all studies.18,29,31 These studies dem-
onstrate that graft porosity causes systemic pressure
in the aneurysm sac (MPI> 0.9) (Fig. 5).
Aneurysm sac pressure with type V endoleak
Patient-studies
The MPIs in patients with expanding aneurysms
without detectable endoleak vary from 0.27 to 1.12
(Fig. 6, red lines).14,46e50
Dias et al. measured MPIs in patients with shrink-
ing, stable and expanding aneurysms after EVAR
without detectable endoleak. Although the number
of patients was too small for definitive conclusion,
they associated a MPI above approximately 0.35
with a subsequent AAA expansion.14 This corre-
sponds with findings of other studies (Fig. 6).
Animal-studies
The MPIs with type V endoleak in the animal-study
by Skillern et al. vary from 0.91 to 1.01 (Fig. 6, green
line).51
Fig. 5. MPI with type IV endoleak in patient-studies (red),
animal-studies (green) and in-vitro studies (blue). Type of
pressure measurement device is given by (F) fluid filled or
(NF) non-fluid filled device.
Fig. 6. MPI with type V endoleak in patient-studies (red),
animal-studies (green) and in-vitro studies (blue). Type
of pressure measurement device is given by (F) fluid filled
or (NF) non-fluid filled device.In-vitro studies
Gawenda et al. investigated determinant of endoten-
sion in an in-vitro study. The MPIs range from 0.19
to 0.57.50,52
Discussion
This review demonstrates that the MPI after EVAR
without detectable endoleak differ widely between
studies. This can be understood since the aneurysm
sac pressure is mulitfactorial. The presence of efferent
side branches, the size of endoleak, the type of graft,
the mechanical properties of the aneurysm wall and
the aneurysm volume have been investigated as de-
terminants of aneurysm sac pressure.18,31,50,52,53
Stent-graft deployment, in absence of an endoleak,
does not result in immediate reduction of intra-sac
pressure of many patients (Fig. 1A).
Since aneurysm sac pressure is a direct determi-
nant of aneurysm wall stress, the risk of aneurysm
rupture is not immediately reduced after successful
EVAR. Pressure reduction in the aneurysm sac takes
some time varying from 1 week to two years in
most cases whereas sometimes pressure reduction
never takes place (Fig. 1AeD). Theoretically, the aneu-
rysm sac pressure decreases only if there is an outflow
or resorption since the aneurysm sac is filled with in-
compressible material. The rate of pressure reduction
depends on the outflow resistance in the efferent ves-
sels and the rate of resorption which is influenced by
biochemical factors. Hence it is understandable that
time is needed before pressure reduction will take
place.
The MPIs in in-vitro studies are lower. This
might be explained by misdiagnosing endoleaks in
in-vivo studies. However, differences between the
in-vitro experimental set-up and the in-vivo situa-
tion also contribute to the low MPI in in-vitro stud-
ies. In-vitro models are only appropriate to evaluate
aneurysm sac pressure after successful EVAR if the
stent-graft is deployed in a running artificial circula-
tion. During some in-vitro studies the aneurysm sac
was separately filled after deployment of a stent-
graft.12,23,25 Of course, the aneurysm sac pressure
in this set-up depends on the amount of liquid in-
jected in the aneurysm sac and misrepresents the
in-vivo aneurysm sac pressure after successful stent-
graft deployment.
Pulse pressure is reduced after EVAR. Persistence
of systemic pulse pressure in the aneurysm sac and
aneurysm pulsatility have been considered as an im-
portant guide to evaluate the success of EVAR.21,54
However, Mehta et al. demonstrated that the
Eur J Vasc Endovasc Surg Vol 34, October 2007
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lute aneurysm sac pressures, but appeared to be de-
pendent on the presence or absence of side-branch
outflow. Therefore, they concluded that aneurysm
pulsatility is an unreliable guide to predict aneurysm
sac pressurization.19
Endoleak
The type of endoleak does not directly correlated to
the aneurysm sac pressure, because great differences
exist between studies in which identical type of endo-
leaks are investigated. We will discuss the results of
various types of endoleaks separately.
Type I and III endoleak
Type I and III endoleaks are considered as the most
dangerous, even if sealing appears to have occurred.4
Ruptures have been reported with EVAR associated
with these types of endoleaks.3 The level of MPIs in
Figs. 2 and 4 are probably high enough to contribute
to aneurysm sac rupture. These endoleaks are often
associated with ‘‘systemic’’ pressure in the aneurysm
sac. However, even in the presence of these endoleaks,
not every study demonstrates MPIs of 1.0 (Figs. 2 and
4). Differences between studies are probably caused
by the presence or absence of outflow from the aneu-
rysm sac. The levels of the MPI are less in the presence
of an outflow channel (Fig. 4).19,23,31 Theoretically, the
pressure in the outflow channel influences the aneu-
rysm sac pressure since it determines the outflow re-
sistance. Low outflow resistance enhances its ability
to depressurize the aneurysm sac (also in the presence
of an endoleak).
Type IV
If the stent-graft is permeable for blood (type IVendo-
leak), the MPI will be around 1.0 (Fig. 5).18,29,31 The
pressure reduction in the aneurysm sac after stent-
graft placement was inversely correlated with the
porosity of the graft material.29
Type V
The mechanism of type Vendoleaks is still unclear. En-
dotensionmay represent a very low flow endoleak that
is not visualized with conventional imaging. Risberg
et al. described a theory that degradation of aneurysm
sac thrombus with formation of proteins and protein
particles may cause osmotic pressure.47 Ultrafiltration
through a PTFE graft (persistent type IV) has also
been discussed as cause of endotention.47,55 Although
the pathogenesis of endotension (AAA growth with-
out detectable endoleak) remains unclear, it is
Eur J Vasc Endovasc Surg Vol 34, October 2007hypothesized that an elevated aneurysm sac pressure
is a contributory factor.49 Several studies demonstrated
significant aneurysm sac pressures in the presence of
endotension (Fig. 6).14,46e49 Pressure transmission
through thrombosed attachment site failure (throm-
bosed type I) has also been considered as cause of
endotension.51 However, elevated aneurysm sac pres-
sure itself is probably not the only explanation for
endotension since an increase in sac volume cannot
occurwithout accumulation ofmore luminal content.49
Type II
In the presence of a type II endoleak, all patient stud-
ies demonstrated a significant pressurization of the
aneurysm sac in the first month after EVAR with
type II endoleaks (Fig. 3A). However, in view of the
fact that the aneurysm sac is not depressurized imme-
diately after EVAR in absence of any endoleak
(Fig. 1A), it is not absolutely certain that ‘‘systemic’’
aneurysm sac pressure is caused by the presence of
a type II endoleak.
Side-branches can act as afferent (feeding) and ef-
ferent (outflow) vessels depending on the pressure
gradient between aneurysm sac and side branch.16,18
Vallabhaneni et al. measured pressures within pat-
ent lumbar arteries after restoration of iliac blood
flow during open aneurysm surgery.21 The pressure
did not rise to the levels recorded within the aneu-
rysm after endograft deployment. They suggest that
retro-grade perfusion via patent side-branches cannot
be the only explanation for maintenance of pressure
within the aneurysm sac.
Since the mean aneurysm sac pressure immediately
after successful EVAR is similar to the systemic mean
pressure (Fig. 1A), the aneurysm sac pressure level
is higher than the pressure level in the side
branches.21 This means that the non-thrombosed
side branches of the aneurysm will be efferent vessels
immediately after EVAR. The level of aneurysm sac
pressure will decrease to the pressure level in the pat-
ent side branches.18,31,56 This pressure reduction prob-
ably takes time, as can be derived from literature
findings that the MPIs of aneurysms with a type II en-
doleak more than 1 month after EVAR13,14 are gener-
ally lower than MPIs measured at an earlier date
(Fig. 3A). This is supported by data of the animal
studies by Pitton et al., in which is demonstrated
that the MPI decreases during the period from 6
weeks to 6 months (Fig. 3B).15,16
Considering these findings, the situation may be
comparable immediately after EVAR without endo-
leak and with type II endoleak; a time interval in
both situations is needed before the depressurization
of the aneurysm sac takes place. The extent of
439Aneurysm Sac Pressure after EVARpressure reduction will be less in the presence of
a type II endoleak, because in this situation the aneu-
rysm sac pressure will not decrease beneath the pres-
sure level in the side branch.18,31,56 Hence, the risk of
type II endoleaks depends on the side branch pressure
level. Furthermore, pressure level in side branches
differs individually from patient to patient which
results in different MPIs.
We accept that direct comparison of studies is
hampered by different methods of reporting, differ-
ent measurements of systemic pressure (peripheral
or central), different time of measurement and
different measuring techniques, but comparison of
the material is needed to determine the value of
aneurysm sac pressure monitoring during follow-up
after EVAR. We took these factors into account to
compare the results of different studies in the best
possible way.
As mentioned, this review demonstrates that the
MPI after EVAR differs between studies in which
same type of endoleaks are investigated. Hence the
risk of aneurysm rupture and therefore the need for
re-intervention could differ per patient. This explains
why identical types of endoleaks, as detected by
imaging techniques, probably do not have identical
clinical relevance. Therefore, continuous aneurysm
sac pressure monitoring by wireless pressure sensors
could be a valuable tool to estimate the risk of aneu-
rysm rupture.57 Unfortunately, aneurysm sac pressure
monitoring is probably not that straightforward,
because pressure measurements are often performed
in a thrombosed aneurysm sac. Differences in pres-
sure readings under identical pressure conditions
could occur caused by the thrombus.58,59 Future
research is needed to develop accurate methods of
aneurysm sac pressure measurements and to evaluate
the pitfalls of aneurysm sac pressure monitoring. Fur-
thermore, patient studies with continuous aneurysm
sac pressure monitoring are needed to determine the
threshold of MPI when re-intervention is necessary
to prevent aneurysm rupture.
In conclusion, MPIs differ widely in the presence
as well as in absence of an endoleak. MPIs are not
specific to the type of endoleak, because the deter-
minants of aneurysm sac pressure are multi-facto-
rial. This implies that the same type of endoleaks,
detected by imaging, probably does not cause an
identical risk of aneurysm rupture. Wireless aneu-
rysm sac pressure monitoring could be valuable
tool during follow-up after EVAR. However, further
research is necessary to investigate the pitfalls of
aneurysm sac pressure measurements before the
clinical relevance of aneurysm sac pressure monitor-
ing can be evaluated.Acknowledgment
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